Skip to content
NHQualityCampaign.orgIndependent nursing home quality resource
Abuse & NeglectFor families

Chemical Restraints in Nursing Homes: Signs and Resident Rights

A chemical restraint is a drug given for discipline or staff convenience rather than to treat a medical symptom, and federal rules prohibit it. Antipsychotics and sedatives are the usual concern, especially for people with dementia.

Updated 4 min readHow we research
Pills spilling from an orange prescription bottle
Photo: Towfiqu barbhuiya (Unsplash License). Credits

What is a chemical restraint?

CMS describes a chemical restraint as any drug used for discipline or staff convenience and not required to treat medical symptoms. "Convenience" means using a drug to control behavior or reduce a resident's activity with less effort by staff, rather than in the resident's interest. The same drug can be appropriate for one resident and a restraint for another; the purpose and the evidence of need make the difference.

The drugs most often involved are antipsychotics, such as haloperidol or quetiapine, and sedatives such as benzodiazepines. These links lead to general drug information, not advice about any individual's treatment.

What the rules say

  • 42 CFR 483.10(e)(1) and 483.12(a)(2): residents have the right to be free from physical or chemical restraints imposed for discipline or convenience and not required to treat medical symptoms.
  • 42 CFR 483.45(d) and (e): residents must be free from unnecessary drugs; psychotropic drugs require a documented diagnosis and indication, gradual dose reductions and behavioral interventions unless clinically contraindicated, and PRN psychotropic orders are generally limited to 14 days.
  • Since 28 April 2025 (QSO-25-14-NH), surveyors cite chemical restraints and unnecessary psychotropic medications together under F605.
  • Residents and their representatives have the right to be informed of and to refuse treatment.

Warning signs of chemical restraint or overmedication

  • A resident who suddenly sleeps most of the day or is hard to wake
  • New confusion, slurred speech, drooling, shuffling gait or stiffness
  • New falls after a medication change
  • Loss of appetite, weight loss or trouble swallowing
  • Withdrawal from activities and family
  • Staff describing the resident as "easier to manage" since a new drug
  • A new diagnosis such as schizophrenia late in life with no psychiatric history

Questions to ask the care team

  1. What drug was started, when, and who prescribed it?
  2. What symptom is it treating, and how is that symptom being measured?
  3. What non-drug approaches were tried first? See non-drug approaches.
  4. Was I (or the resident) told about the risks and asked for consent?
  5. When will a gradual dose reduction be tried?
  6. Has the pharmacist's monthly review flagged anything?

What to do if you suspect a chemical restraint

  1. 1
    Request a care plan meeting
    Ask for the physician, nurse and, if possible, the consultant pharmacist. See care plan meetings.
  2. 2
    Ask for records
    Request the medication administration record, physician orders, behavior monitoring notes and consent forms.
  3. 3
    Ask for a review
    Ask for a medication review and a dose-reduction plan. Request a second opinion if needed.
  4. 4
    Report
    If concerns are not addressed, contact the ombudsman and state survey agency. Using drugs for staff convenience is a form of abuse.

When psychotropic drugs can be appropriate

Not every psychotropic medicine in a nursing home is a restraint. Some residents have long-standing psychiatric illnesses, severe depression or distressing psychotic symptoms that put them or others at risk, and medication may be part of good care. What the rules require is a documented diagnosis and clinical reason, monitoring for benefit and side effects, attempts at the lowest effective dose, and non-drug approaches alongside. Ask to see that reasoning in the record.

Checking a home's record

Care Compare reports the share of long-stay residents who received an antipsychotic medication. Look for F605 citations in inspection reports. Since 2012 the National Partnership to Improve Dementia Care has pushed homes to reduce antipsychotic use; see antipsychotic reduction for what good practice looks like.

Back to the nursing home abuse guide, or see types of abuse.

Frequently asked questions

What is considered a chemical restraint in a nursing home?

Any drug used for discipline or staff convenience rather than to treat a resident's medical symptoms. Antipsychotics, benzodiazepines and other sedatives are the usual concern. Using a drug mainly to keep a resident quiet or less active is prohibited under federal nursing home rules.

Can a nursing home give antipsychotics without consent?

Residents and their representatives have the right to be informed about treatment and to refuse it, and CMS expects facilities to discuss risks and benefits of psychotropic drugs before starting them. Specific consent requirements vary by state. If a drug was started without discussion, ask the care team and contact the ombudsman.

What F-tag covers chemical restraints?

F605. Since 28 April 2025, CMS guidance (QSO-25-14-NH) combines chemical restraints and unnecessary psychotropic medications, previously cited partly under F758, into F605, the right to be free from chemical restraints.

What are signs a nursing home resident is overmedicated?

Excessive sleepiness, new confusion, slurred speech, unsteady walking or falls, stiffness, drooling, poor appetite and withdrawal can all signal overmedication. These can also have other causes, such as infection, so report changes promptly and ask for a medication review.

Confidential request

Request legal help

If you believe a loved one was abused or neglected in a nursing home, you can ask to be contacted by a participating attorney or attorney referral service.

We are not a law firm.

NHQualityCampaign.org is not a law firm and does not provide legal advice. Submitting a request does not create an attorney-client relationship. We may share your request with a participating attorney or attorney referral service, which may pay for advertising. No attorney is guaranteed to accept your matter. Prior results do not guarantee a similar outcome, and results vary. This may be considered attorney advertising in some states.

Sources

  1. CMS: State Operations Manual, Appendix PP (nursing home guidance to surveyors)
  2. eCFR: 42 CFR 483.12, Freedom from abuse, neglect and exploitation
  3. eCFR: 42 CFR 483.45, Pharmacy services
  4. CMS: Quality, Safety and Oversight memos (QSO-25-14-NH)

Medical disclaimer. This page is general education, not medical, legal or financial advice, and it does not replace the judgment of a qualified clinician who knows the resident. Do not start, stop or change any medication without talking to the prescriber. In an emergency, call 911.

Attorney advertising and legal disclaimer. NHQualityCampaign.org is not a law firm and does not provide legal advice. Submitting a request does not create an attorney-client relationship. We may share your request with a participating attorney or attorney referral service, which may pay for advertising. No attorney is guaranteed to accept your matter. Prior results do not guarantee a similar outcome, and results vary. This may be considered attorney advertising in some states. If someone is in immediate danger, call 911.

Independent resource. NHQualityCampaign.org is an independent educational resource. It is not affiliated with, endorsed by or operated by the Centers for Medicare & Medicaid Services (CMS), the U.S. Department of Health and Human Services (HHS), any government agency, or the original Advancing Excellence in America’s Nursing Homes campaign or its sponsors. Historical campaign information is summarized with attribution for educational purposes.